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Confirmatory factor analysis of the thyroid-related
quality of life questionnaire ThyPRO
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Åse Krogh Rasmussen1, Laszlo Hegedüs5, Steen Joop Bonnema5 and Jakob Bue Bjorner2,6,7
Abstract
Background and aim: Thyroid diseases are prevalent and chronic. With treatment, quality of life is restored in
most, but not all patients. Construct validity of the thyroid-related quality of life questionnaire, ThyPRO, has been
established by multi-trait scaling, but not evaluated with more elaborate methods. The purpose of the present study
was to evaluate dimensionality of the ThyPRO scales and to attempt to understand possible item misfit through
structural equation modeling for categorical data.
Methods: The current 85-item version of ThyPRO consists of 13 scales, covering domains of physical (4 scales) and
mental (2 scales) symptoms, function and well-being (3 scales) and participation/social function (4 scales). The data
were collected from a cross-sectional sample of 907 thyroid patients. One-factor confirmatory models were
fitted to each scale, and evaluated by model fit statistics (comparative fit index >0.95, root mean square error of
approximation <0.08), magnitude of factor loadings, model residual correlations and modification indices (MI).
Indications of multi-dimensionality were tested in bi-factor models. Possible item misfit was evaluated in a
combined, investigational model.
Results: Each ThyPRO scale was adequately represented by a unidimensional model after minor revisions.
Eleven items were identified in the unidimensional models as potentially misfitting and were investigated
further by multidimensional modeling.
Conclusion: Elaborate psychometric modeling supported the construct validity of the ThyPRO. However, 11
potentially misfitting items and 18 items with local dependence to other items are candidates for removal in
future item reduction processes.
Keywords: Patient-reported outcomes, Unidimensionality, Quality of life, Scale validation, Thyroid disease
Introduction
Thyroid diseases are diseases related to the thyroid
gland, which is an endocrine, i.e. hormone producing,
gland located in the front of the neck. Thyroid diseases
are prevalent, affecting approximately 15% of individuals
of all ages, with a 4 to 1 women/men ratio [1,2]. The
main disease groups comprise non-toxic goiter (enlargement
of the gland), hyperthyroidism (either as toxic nodular goiter
or Graves’ disease -with or without Graves’ orbitopathy (GO,
inflammation and protrusion of the eyes)) - and
autoimmune hypothyroidism. The symptomatology is
often diffuse, sharing features with many other dis-
eases (fatigue, palpitations, dry skin, depression, un-
easiness, etc.) as well as with the non-pathological
fluctuations of well-being and function in life. There-
fore, thyroid diseases may go un-diagnosed for many
years in some patients and at the time of diagnosis,
most patients have reduced quality of life [3,4]. The
diseases are chronic, but relevant treatment is avail-
able. In general though, there is a lag in treatment ef-
fect for thyroid diseases of up to several months and
population-based studies document excess morbidity
and mortality, also when adequately treated [5,6].
Eventually, the quality of life of the majority of pa-
tients is restored [4,7]. However, studies indicate that
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a substantial minority do not regain their premorbid
level of well-being and function [8,9]. Valid and reliable
measures of health-related quality of life are necessary in
order to describe the patients’ experiences of the diseases
adequately and for intervention studies attempting to
improve treatment efficacy. Therefore, there has been a
growing interest within thyroidology in measuring patient-
reported outcomes (PRO), leading to the development of a
comprehensive PRO measuring thyroid-related quality of
life, the ThyPRO. Due to the fact that individual thyroid
diseases often co-exist (e.g., goiter and hyperthyroidism)
and that treatment of one disease entity may lead to an-
other (e.g., removal of a goiter leading to hypothyroidism),
the ThyPRO was developed as a comprehensive thyroid-
related measure, aimed at any benign thyroid disease.
The content of the ThyPRO addresses the impact of all
benign thyroid diseases [10,11]. The validation of the
current version has included evaluation of clinical validity
in terms of known-groups comparisons and reliability in
terms of internal consistency and test-retest reliability
[12,13]. Further, the ThyPRO’s dimensionality or construct
validity has been established by multi-trait scaling [12].
However, within such a framework, it is not possible to
test the overall fit of a model [14], nor can misfit of items
be modeled specifically.
The growing interest in applying the ThyPRO in clinical
studies [7,15,16] and even in daily clinical practice has
motivated efforts to develop shorter versions of the instru-
ment as well as versions applicable to ecological moment-
ary assessments. Development of such versions can be
informed by the application of item response theory (IRT)
models, which also provide a more detailed description of
measurement precision and can provide data for interpret-
ability of the ThyPRO. However, IRT models require add-
itional, more detailed examinations of the dimensionality
of the ThyPRO scales.
Structural equation models provide a latent variable
modeling framework that is useful in detailed examinations
of dimensionality. The measurement part of structural
equation models can be used to assess the dimensionality
of measured variables such as questionnaire items, using
confirmatory factor analysis (CFA) for categorical data.
Structural equation modeling can also test relationships
among modeled latent variables (i.e., structural part of
the models) [17-21]. We will exploit the former in the
detailed analyses of the dimensionality of the ThyPRO
scales, including overall test of model fit. We will use
the structural part of the modeling approach when
attempting to understand, through investigative model-
ing, any possible item misfit identified during the CFA
step.
Thus, the purpose of the present study was to evaluate
dimensionality of the ThyPRO scales in a sample of pa-
tients with a broad spectrum of thyroid diseases and to
attempt to understand possible item misfit through in-
vestigative structural equation modeling.
Methods
The ThyPRO questionnaire
The current 85-item version of ThyPRO measures quality
of life in 13 scales, covering physical (4 scales) and mental
(2 scales) symptoms, function and well-being (3 scales)
and participation/social function (4 scales) and one single
item about overall quality of life. Content and scale struc-
ture were derived from a literature search [8] and from ex-
pert and patient interviews [10] and the development was
conducted within a classical health-related quality of life
theoretical framework [22-25]. Items are rated on a five-
point scale from 0 = not at all to 4 = very much, with a ref-
erence period of 4 weeks. Thirteen scales are scored by
reverting positively worded items and rescaling item
scores from 0 (best QoL - absence of symptoms) to 100
(worst QoL – maximum level of symptoms) and taking
the average across the items in the scale – i.e., standard
summation and linear transformation.
Patient population
The patient population comprised a cross-sectional sample
of 907 patients attending two university hospital endocrine
outpatient clinics during 2007 (Table 1 (For further details,
see reference [13])). At one center, all consecutive patients
newly referred to the clinic were invited to participate; at
the other center, all patients attending the clinic during a
specified period of time were invited, regardless of their re-
ferral time. Thus, patients from the former were mainly
newly diagnosed whereas from the latter most were already
receiving treatment. All common benign thyroid diagnoses
were represented, as were various stages of disease and
treatment. Clinical description of the patients included
physical examination, ultrasonographic imaging and bio-
chemical testing. The overall response rate was 69%. The
project was approved by the local ethical committee (KF01
2006–1579) and the Danish Data Protection Agency and
was registered at ClinicalTrials.gov (NCT00150033).
Statistical analyses
Prior to any of the statistical analyses mentioned below, a
content analysis of each scale was performed to identify
items which might be less associated with the remaining
items in the same scale, and item pairs which might be
closely related to one another after being accounted for by
the scale (local item dependence). This was done to pro-
vide a content-based guidance to model fitting.
Then a one-factor confirmatory model for ordinal data
was fitted to each individual scale [26,27], using Mplus
(version 7.11) [28]. The ordinal items were regressed on
the scale-factor by probit regressions estimated by a ro-
bust weighted least squares estimator with mean and
Watt et al. Health and Quality of Life Outcomes 2014, 12:126 Page 2 of 12
http://www.hqlo.com/content/12/1/126
variance adjustment (WLSMV) [28,29]. Appropriateness
of the initial one-factor model for each scale was assessed
by: 1) overall goodness-of-fit statistics including the com-
parative fit index (CFI) and the root mean square error of
approximation (RMSEA), where CFI >0.95 and RMSEA <
0.08 were regarded as appropriate fit [30-34]; 2) magni-
tude of factor loadings; 3) model residual correlations
(RC) and 4) modification indices (MI) [28,35]. For the
latter three criteria, their magnitude was evaluated in
comparison to other items in the scale and in an integra-
tive manner, taking all three under consideration at once,
so no strict thresholds were applied for each criterion. In
general though, modification indices >100 and residual
correlations > |.10| were taken as indices of lack of fit
(local dependence or lack of convergent validity), but
smaller values could also give rise to model revision con-
siderations, if several indices pointed in the same direc-
tion; e.g., if an item had a modification index of 40 for a
specific residual correlation (a “WITH”-statement in
Mplus) and also had residual model correlations with sev-
eral items. Revisions to improve model fit were based on
both confirmatory factor modeling and content analysis,
including specification of residual correlations among
items, omission of poorly associated items from the
models, and specification of sub-factors (for example
among positively worded items in a scale). For scales
where secondary factors seem plausible, a bifactor model
was fitted to evaluate the dominance of the primary factor
when secondary factors were modeled. A bifactor model
specifies that each item is regressed on both a general and
a group (secondary) factor, and the general and group fac-
tors are uncorrelated with each other [34,36-39]. The
magnitude of loadings on the general and group factors
were compared. The two-item scale on impaired sex life
was not examined in this step, since a separate factor ana-
lysis of a two-item scale is not useful.
In an attempt to understand any possible item misfit
identified through individual scale analyses, hypotheses
which could explain the misfit were sought. These hypo-
theses were evaluated in a combined, investigational
multidimensional model, where the individual scale fac-
tors were allowed to correlate freely. Also items were
cross-loaded on multiple scale factors when necessary to
explore a better understanding of item misfit. For
example, if an item in a physical symptoms scale, e.g.,
“Palpitations”, had low own-factor loadings, it could be
hypothesized that this was due to palpitations being influ-
enced by mental health, e.g., as part of anxiety. Then
cross-loading of this item on the mental symptoms scales
would be specified and evaluated in the combined model.
In order to examine the stability of the model across
various estimation techniques, the overall final model
was compared with graded response multidimensional
IRT models [40], fitted with the Mplus program [28].
For computational reasons, a 13-dimensional IRT model
could not be estimated, so the model was broken down
to four separate models, each containing scales with
cross-loadings across scales. Stability was examined by
comparing the estimated factor scores for each patient
from the SEM vs. the IRT-model using intra-class
correlations.
Results
Fitting unidimensional models to each individual ThyPRO
scale
Table 2 shows the results of the content analyses and
the confirmatory factor analyses of the ThyPRO scales in
their current version. In general, loadings were high in
all scales and CFI was also high for the vast majority of
scales. In contrast, for most scales, RMSEA was not
below the 0.08 threshold for appropriate fit. Model pa-
rameters indicative of item misfit are presented to the
right in Table 2. The consequential remodeling resulted
in the revised scales presented in Figure 1 and the re-
modeling as well as the overall goodness-of-fit statistics
are described separately for each scale in the following
text.
Table 1 Characteristics of the N = 907 patients
Women (%)/men 787 (87)/120
Age (mean (SD)) 51 (15)
Diagnosis (n (%)):
Diffuse non-toxic goitre 18 (2)
Multinodular non-toxic goitre 154 (17)
Uninodular non-toxic goitre 68 (7)
Solitary cyst 19 (2)
Multinodular toxic goitre 108 (12)
Uninodular toxic goitre 37 (4)
Graves’ hyperthyroidism 168 (19)
Graves’ orbitopathy 94 (10)
Autoimmune hypothyroidism 199 (22)
Subacute thyroiditis 9 (1)
Postpartum thyroiditis 8 (1)
Other thyroid disease 25 (3)
Months since diagnosis (median (range))* 27 (−0.9-607)
Thyroid treatment (n (%)):
No thyroid treatment (ever) 283 (31)
Antithyroid medication 162 (18)
L-Thyroxine 292 (32)
Radioiodine 114 (13)
Thyroidectomy 132 (14)
Other treatment 4 (0.4)
*Negative durations reflect patient responding to the questionnaire before a
final thyroid diagnosis was established.
Watt et al. Health and Quality of Life Outcomes 2014, 12:126 Page 3 of 12
http://www.hqlo.com/content/12/1/126
Table 2 Content analysis and confirmatory factor analyses of the individual ThyPRO scales
Scale and item
Possiblemisfit fromcontent
analysis Initial unidimensionalmodela
Item#
Abbreviated item
content
Unrelated
content
Local
dependence
Factor
loading
Indication of local
dependenceb
Indication of
itemmisfitc
Goiter Symptoms CFI=0.95 RMSEA=0.16(0.15-0.16)
2a Sense of fullness in neck 0.87 MI: LD with 2b
2b Visible swelling on neck 0.60 MI and RC: LDwith 2a Low loading
2c Pressure in throat 0.90 RC: LDwith 2g
2d Pain in front of neck With 2e 0.71
2e Throat pain felt in ears * With 2d 0.60 Low loading and low IC
2f Lump in throat 0.85
2g Clear throat often * 0.69 MI: LDwith 2l, RC: LDw. 2c
2h Discomfort swallowing With 2i 0.94 MI: LD with 2i
2i Difficulty swallowing With 2h 0.92 MI: LD with 2h
2j Sense of suffocating 0.73
2l Hoarseness * 0.56 MI: LD with 2g Low loading
Hyperthyroid Symptoms CFI=0.80 RMSEA=0.18(0.17-0.19)
2m Trembling hands 0.60
2n Increased sweating With 2o, 2p, 2q 0.71 MI: LD with 2q
2o Palpitations With 2n, 2p 0.69
2p Shortness of breath With 2n, 2o 0.64
2q Sensitive to heat With 2n 0.70 MI: LD with 2n
2s Increased appetite 0.54
2t Loose stools With 2u 0.75 Low IC and large neg. RCs
2u Upset stomach With 2t 0.80
Hypothyroid Symptoms CFI=0.98 RMSEA=0.10(0.06-0.14)
2r Sensitive to cold 0.56
2ff Swollen hands or feet 0.62
2gg Dry skin With 2hh 0.86 RC: LDwith 2hh
2hh Itching skin With 2gg 0.63 RC: LDwith 2gg
Eye Symptoms CFI=0.94 RMSEA=0.11(0.09-0.11)
2w Watery eyes With 2y, cc, dd 0.62 MI and RC: LDwith 2x
2x Bags under the eyes 0.59 MI and RC: LDwith 2w
2y Grittiness in eyes With 2w, 2cc, 2dd 0.74
2z Reduced sight * 0.68
2aa Pressure in eyes With 2cc 0.87 MI: LD with 2cc
2bb Double vision * 0.70
2cc Pain in eyes With 2w, y, dd, aa 0.86 MI: LD with 2aa
2dd Sensitive to light With 2w, y, cc 0.70
Tiredness CFI=0.99 RMSEA=0.28(0.26-0.28)
3a Been tired 0.90 MI: LD with 3b
3b Been exhausted 0.93 MI: LD with 3a
3c Difficult get motivated 0.89
3d Felt worn out 0.91
4a Full of life With 4b, 4c 0.93 MI and RC: LDwith 4b, 4c
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Table 2 Content analysis and confirmatory factor analyses of the individual ThyPRO scales (Continued)
4b Energetic With 4a, 4c 0.98 MI and RC: LDwith 4a, 4c
4c Able to copewith life With 4a, 4b 0.95 MI and RC: LDwith 4a, 4b
Cognitive Complaints CFI=0.99 RMSEA=0.13(0.11-0.15)
5a Problems remembering With 5c 0.87 RC: LDwith 5d
5b Slow or unclear thinking With 5f 0.94
5c Difficulty finding words With 5a 0.85
5d Been confused * 0.85 RC: LDwith 5a
5e Difficulty learning 0.92 MI: LD with 5f
5f Difficulty concentrating With 5b 0.91 MI: LD with 5e
Anxiety CFI=0.97 RMSEA=0.16(0.14-0.18)
6a Nervous 0.90 MI: LD with 6b
6b Afraid or anxious 0.90 MI: LD with 6a
6c Felt tension 0.88
6d Afraid being seriously ill * 0.70 Low loading, neg. RC’s
6e Uneasy With 6f 0.92 MI: LD with 6f
6f Restless With 6e 0.80 MI: LD with 6e
Depressivity CFI=0.96 RMSEA=0.24(0.23-0.26)
7a Sad 0.95
7b Depressed With 7c 0.92
7c Discouraged With 7b 0.94
7e Crying easily * 0.79 MI: LD with 7f
7f Unhappy With 7g 0.92 MI: LD with 7e
7g Happy With 7i, 7f 0.76 MI: LD with 7i
7i Self-confident * With 7g 0.74 MI: LD with 7g
Emotional Susceptibility CFI=0.92 RMSEA=0.24(0.23-0.25)
8a Difficulty coping 0.80
8b Not like yourself 0.80
8c Easily stressed 0.81 MI: LD with 8i
8d Mood swings 0.88
8e Irritable With 8g 0.89 Large neg. RC
8f
Frustrated 0.91
MI: LD with many
other items
8g Angry With 8e 0.80
MI: LD with many
other items
8h
Felt in control With 8i 0.87
MI: LD with many,
large neg. RC’s
8i Felt in balance With 8h 0.91 MI: LDwith 8i, 8c
Impaired Social Life CFI=0.99 RMSEA=0.08(0.05-0.13)
10a Difficult with people 0.90
10b A burden to people 0.89
10c Conflicts with people 0.80
10e Others lack understanding * 0.71 Low loading, neg. RC’s
Impaired Daily Life CFI=0.99 RMSEA=0.10(0.08-0.12)
11a Difficult manage life 0.94
11b Limit leisure activities With 11f 0.95 MI: LD with 11f
11c Difficult participate in life 0.96
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Goiter Symptoms
Three items were problematic (2b Visible swelling in front
of neck, 2e Throat pain felt in ears and 2l Hoarseness),
with relatively low loadings and indication of local de-
pendence with other items. Two of these items were iden-
tified prior to the modeling as potentially less related to
the concept. Two instances of local dependence among
other items were identified (2c Pressure in throat vs. 2 g
Need to clear throat often and 2 h Discomfort swallowing
vs. 2i Difficulty swallowing, Table 2). When omitting the
three items and modeling the local dependencies, an
appropriately fitting unidimensional model was reached
(Figure 1, CFI = 0.99, RMSEA(90%CI) = 0.08(0.07-0.09)).
Hyperthyroid Symptoms
For one pair of items (2n Increased sweating vs. 2q Sensi-
tive to heat), the modification index suggested local
dependence and one item (2t Loose stools) had large
negative residual correlations with other items, when the
initial model was estimated. When omitting the latter and
fitting the local dependence, a unidimensional model ob-
tained an appropriate fit to the data (Figure 1, CFI = 0.97
RMSEA(90%CI) = 0.06(0.05-0.08)).
Hypothyroid Symptoms
When modeling the expected local dependence between
the items concerning skin (2gg Dry skin vs. 2hh Itching
skin), an appropriate fit between an overall unidimen-
sional model and data was demonstrated for this scale
(Figure 1, CFI = 1.0 RMSEA(90%CI) = 0.00(0.00-0.09).
Eye Symptoms
With the specification of two local dependence-pairs
(2w Watery eyes vs. 2x Bags under eyes and 2aa Pressure
in eyes vs. 2cc Pain in eyes), an appropriate fit of a
unidimensional model was found (Figure 1, CFI = 0.99
RMSEA(90%CI) = 0.06(0.04-0.07).
Tiredness
Despite quite high factor loadings, overall goodness-of-
fit was poor for this scale. To avoid floor problems,
three items had been formulated positively for this
scale. The positively worded items had high positive
residual correlations and modification indices. A bi-
factor model distinguishing positively from negatively
worded items was therefore evaluated (Figure 2, Panel
A). Although the positively worded items had high load-
ings on the positive factor (Vitality), loadings on the
general factor were higher. When modeling the local
dependence among positively worded items as residual
correlations and also allowing for the local dependence
between 3a and 3b, the model had good fit (Figure 1,
CFI = 1.0, RMSEA(90%CI) = 0.02 (0.00-0.04).
Cognitive Complaints
All items had high loadings in the initial model (Table 2).
When specifying two pairs of local dependence,
suggested by modification indices (5a Problems remem-
bering vs. 5d Been confused and 5e Difficulty learning
vs. 5f Difficulty concentrating), overall model fit was ap-
propriate (Figure 1, CFI = 1.0 RMSEA(90%CI) = 0.07
(0.05-0.09)).
Anxiety
According to overall goodness-of-fit indices, the initial
model did not obtain an appropriate fit to the data
(Table 2). When fitting a model by excluding the item
identified as less related with the other items (6d Afraid
Table 2 Content analysis and confirmatory factor analyses of the individual ThyPRO scales (Continued)
11d Difficult getting around * 0.84 MI: LD with 11e
11e Everything takes longer * 0.85 MI: LD with 11d
11f Difficulty managing job With 11b 0.88 MI: LD with 11b
Cosmetic Concern CFI=0.98 RMSEA=0.10(0.08-0.12)
13a Disease affect appearance With 13b 0.83 MI: LD with 13b
13b Unsatisfied appearance With 13a 0.98 MI: LD with 13a
13c Camouflage visible signs 0.79
13d Other people looking 0.83
13e Influence on clothes worn 0.79
13g Felt too fat * 0.65 Low loading
aCFI: Comparative fit index, RMSEA: Root mean square error of approximation with 90% confidence interval.
bMI: Modification indices, LD: local dependence, RC: model residual correlation.
cIC: Model inter-item correlation.
Left part of the table presents the results of the initial content analyses. The results of the initial unidimensional confirmatory factor analyses are presented in the
right part of the table: overall goodness-of-fit, factor loadings as well as the indices of possible local dependency and item misfit which lead to remodeling in next
steps of the analyses.
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being seriously ill) and by specifying two item pairs with
local dependence (6a Nervous vs. 6b Afraid or anxious
and 6e Uneasy and 6f Restless), appropriate fit was
obtained (Figure 1, CFI = 1.0, RMSEA(90%CI) = 0.07
(0.04-0.10)).
Depressivity
All items had high loadings (Table 2). However, only after
specification of two local dependence pairs (7e Crying
easily vs. 7f Unhappy and 7 g Happy vs. 7i Self-confident),
was an appropriate overall fit to data reached (Figure 1,
CFI = 1.0 RMSEA(90%CI) = 0.07 (0.05-0.09)).
Emotional Susceptibility
In contrast to most other concepts measured by ThyPRO,
this scale measures a unique aspect of mental health
identified through qualitative analysis of patient inter-
views. Thus, it is not classically described as a separate
concept. It is, however, an important aspect according to
the patients and a prominent feature particularly among
patients with thyroid autoimmunity [10]. According to the
overall fit indices, these items do not appropriately con-
form to a unidimensional model, despite high factor
loadings (Table 2). Several items had high inter-item re-
sidual correlations and were attempted to be modeled
as a separate “Anger” sub-factor (Figure 2, Panel B).
However, as shown in Figure 2, the sub-factor loadings
were rather low. Four items had to be omitted in order
to obtain appropriate fit between a unidimensional
model and the data (Figure 1, CFI = 1.0 RMSEA(90%
CI) = 0.08(0.05-0.11)). A local dependence (8c Easily
stressed vs. 8i Felt in balance) was also modeled.
Goiter Symptoms
2c Pressure in throat
2d Pain in front of neck
2f Lump in throat
2h Discomfort swallowing
2g Clear throat often
2b Visible swelling in front of neck
2j Sense of suffocating
2i Difficulty swallowing
Hyperthyroid Symptoms
2n Increased sweating
2o Palpitations
2p Shortness of breath
2s Increased appetite
2q Sensitive to heat
2u Upset stomach
2m  Trembling hands
Hypothyroid Symptoms2ff  Swollen hands or feet
2gg Dry skin
2hh Itching skin
2r Sensitive to cold
Eye Symptoms
2x Bags under the eyes
2y Grittiness in eyes
2z Reduced sight
2bb Double vision
2aa Pressure in eyes
2cc Pain in eyes
2w  Watery eyes
2dd Sensitive to light
Tiredness
3b Been exhausted
3c Difficulty getting motivated
3d Felt worn out
3a Been tired
Cognitive Complaints
5b Slow or unclear thinking
5c Difficulty finding words
5d Been confused
5f Difficulty concentrating
5e Difficulty learning
5a Problems remembering
Anxiety
6b Afraid or anxious
6c Felt tension
6d Afraid of being seriously ill
6f Restless
6a Nervous
Depressivity
7b Depressed
7c Discouraged
7f Unhappy
7i Self-confident
7g Happy
7a Sad
4b   Energetic
4a Full of life
Emotional Susceptibility
8b Not like yourself
8c Easily stressed
8d Mood swings
8e Irritable
8a Difficulty coping
Impaired Social Life
10b A burden to other people
10c Conflicts with other people
10a Difficult being with other people
Impaired Daily Life
11b Limit leisure activities
11c Difficulty participating in life
11d Difficulty getting around
11f Difficulty managing job
11e Everything takes longer
11a Difficulty managing daily life
Impaired Sex Life 12a Negative influence on sex life 
12b Decreased sexual desire
Cosmetic Complaints
13b Unsatisfied with appearance
13c Camouflage or mask visible signs
13d Bothered by other people looking
13g Felt too fat
13e Influence on clothes worn
13a Disease affect appearance
4c Able to cope with life
.77
.92
.86
.78
.86
.77
.76
.64
.60
.70
.75
.62
.58
.68
.67
.70
.66
.53
.57
.62
.69
.70
.79
.79
.73
.75
.87
.90
.92
.95
.84
.93
.82
.90
.91
.95
.84
.92
.82
.89
.93
.96
.91
.91
.80
.78
.85
.88
.83
.81
.91
.90
.77
.94
.96
.96
.82
.83
.88
.86
.95
.72
.80
.85
.71
.72
.72
2a Sense of fullness in neck .81
2e Throat pain felt in ears
2l Hoarseness
2t Loose stools
6e Uneasy
.87
7e Crying easily.80
8g Angry
8h Felt in control
8i Felt in balance
8f Frustrated
.83
10d People lack understanding
-.19
.29
.22
.28
.24
.42
.41
.43
-.11
.09
.16
.10
.19
.18
.10
.13
.18
.33
Figure 1 Parameter estimates of the unidimensional confirmatory factor analyses of the revised ThyPRO scales. Overall goodness-of-fit of the
models are provided in the text. Grayed out items were omitted during model revision. The two-item Impaired Sexlife scale was not estimated.
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Impaired Social Life
Appropriate, albeit not good overall goodness-of-fit indices
were found for the initial unidimensional model. Excluding
the lowest-loading item (10d People lack understanding),
which was also pre-specified as possibly less associated,
resulted in a just-identified model, hence with perfect fit
(Figure 1, CFI = 1.0 RMSEA(90%CI) = 0.00(0.00-0.00)).
Impaired Daily Life
With the specification of one local dependence (11d
Difficulty getting around vs. 11e Everything takes longer), a
unidimensional model fit the data appropriately (Figure 1,
CFI = 1.0, RMSEA (90%CI) = 0.08(0.07-0.10)).
Cosmetic Complaints
The initial unidimensional model had almost appropri-
ate goodness-of-fit indices (Table 2). When modeling
one local dependence (13a Disease affect appearance vs.
13b Unsatisfied with appearance) and leaving out the
very nonspecific item concerning feeling too fat (13g), a
good fit between model and data was found (Figure 1,
CFI = 1.0 RMSEA(90%CI) = 0.05(0.02-0.08)).
Investigative modeling of possible item misfit within one
combined multidimensional model
This investigative model is presented in Table 3. The hy-
potheses concerning the reason for misfit of the omitted
items are presented in the second column of the table.
In these models, the possible sub-factors tested in bifactor
models (Figure 2) were specified as residual correlations
among the involved items. In the third column of Table 3,
it is specified how these hypotheses were modeled in the
combined multidimensional model, where all the factors
were evaluated simultaneously and were allowed to correl-
ate freely. The results of this investigative modeling are
described in the rightmost column of Table 3. Generally, a
closer association was found between items and their own
scale for the items in the multidimensional model (e.g.
items 2e, 2 t and 10e), than in the unidimensional model
for each scale. For most items, the hypothesized explana-
tions for the apparent misfit were confirmed. Thus, 2b
Visible swelling on neck was indeed associated with
Cosmetic Complaints (−0.23). Item 2l Hoarseness did
load also on the Hypothyroid Symptoms scale (0.22), 2t
Loose stools was negatively associated with particularly
Hypothyroid Symptoms (−0.55), and a negative
A
Fatigue
3a: Been tired
.36
3b: Been exhausted
3c: Difficulty getting motivated
4a: Full of life
3d: Felt worn out
4b: Energetic
4c: Able to cope with life
.36
-.02
.07
.63
.67
.64
Vitality
Tiredness
.86
.90
.94
.94
.72
.73
.72
B
Core
8a: Difficulty coping
.45
8b: Not like yourself
8c: Easily stressed
8e: Irritable
8d: Mood swings
8f: Frustrated
8g: Angry
.33
.25
-.13
.34
.30
.50Anger
Emotional Susceptibility
.78
.80
.81
.95
.85
.88
.74
8h: Felt in control
8i: Felt in balance
.68
.72
.18
-.10
Figure 2 Bi-factor models for the Tiredness (Panel A) and the Emotional Susceptibility (Panel B) scales.
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association between 6d Afraid of being seriously ill and
time since diagnosis was found. In contrast, no rela-
tionship between item 10e Other people lack under-
standing and mental health scales was found. Item13g
Feeling too fat was associated with both Hypothyroid
Symptoms (−0.16), Anxiety (−0.22) and Depressivity
(0.15), and had low loading on its own factor (0.53).
In analyses of concordance of results from SEM and
the IRT-model, high intra-class correlation coefficients
(0.94-0.99) were found for all 13 scales, when comparing
factor scores derived by the SEM with IRT score esti-
mates (Table 4).
Discussion
The purpose of the present study was to evaluate the
dimensionality of the ThyPRO scales and to detect and
understand potential item misfit. Since an established
scale structure already exists for the ThyPRO, we used
a combination of confirmatory factor analyses of the in-
dividual scales and a combined multidimensional model
comprising all 13 ThyPRO scales. In case of misfit for
each individual scale, we revised the model to achieve
the best description of data.
In general, items had high loadings on their own factors
and the comparative fit indices were high, but for the
majority of the scales, the root means square error of
approximation indicated that a simple unidimensional
model was not fitting the data sufficiently well. Based on
prior expectations informed by content analyses, modeling
results (model inter-item correlations and model residual
correlations) and on model modification indices, the
models were adjusted in order to reduce the overall misfit.
For all scales, an appropriate fit according to the overall
goodness-of-fit indices could be reached. During this
process, a total of 11 items were left out of the models
and 18 residual correlations indicating local dependence
were specified.
In most instances, the magnitude of the residual corre-
lations representing local dependencies was small, and
the loading on the relevant general factor was still high.
Most of the residual correlations were among very simi-
larly worded items. Such local dependencies are not prob-
lematic for the current scoring of the ThyPRO, but may
lead researchers to overestimate the precision gained by
the instrument, because locally dependent items provide
less measurement precision than assumed by standard
psychometric analyses [41]. Moreover, one of the items
Table 3 For each item which was omitted during the single-scale analyses, hypotheses regarding possible reasons for
misfit were formulated, modeled and tested as specified
Item Hypothesized reason for misfit Investigative modeling of the
hypothesized reason for misfit
Results of the investigative
modeling
2b Visible swelling on
neck from the Goiter
Symptoms scale
May relate to cosmetic concerns, rather than
being a symptom
Item was allowed to cross-load on the
Cosmetic Complaints factor
Loaded −0.23 on the
Cosmetic Complaints factor.
Loading on own factor: 0.68
2e Throat pain felt in
ears from the Goiter
Symptoms scale
May be relevant only for patients with
subacute thyroiditis, during the acute
inflammatory phase.
No marker of acute inflammation is available
in the clinical database describing the
patients. Only 9 patients in this sample had
subacute thyroiditis
Extraneous modeling not
possible.
Loading on own factor in the
full model: 0.75
2l Hoarseness from
the Goiter Symptoms
scale
Hoarseness is also a classical symptom of
hypothyroidism. Might relate more to
hypothyroidism than to goiter.
Item was allowed to cross-load on the
Hypothyroid Symptoms factor
Loaded 0.22 on Hypothyroid
Symptoms factor.
Loading on own factor: 0.46
2t Loose stools from
the Hyperthyroid
Symptoms scale
Might be a non-specific physical symptom Item was allowed to load on the other
physical symptoms factors, except for Eye
Symptoms
Loaded −0.15 on Goiter
Symptoms factor and −0.55
on Hypothyroid Symptoms.
Loading on own factor: 1.20
6d Afraid of being
seriously ill from the
Anxiety scale
May be related to not being fully examined
yet, and thus an initial fear of e.g. cancer has
not yet been ruled out completely
Item was regressed on time since diagnosis. A significant negative
association with time since
diagnosis was found
10e Other people lack
understanding from
the Impaired Social
Life scale
May relate more to depressive mood and
emotional distress than the other items in
the Social Life scale
Item was allowed to cross-load on the
Depressivity and the Emotional Susceptibility
factor
No significant loading on
Depressivity or Emotional
Susceptibility was found.
Loading on own factor: 1.08
13g Felt too fat from
the Cosmetic
Complaints scale
Weight gain is often experienced during
hypothyroidism. Feeling too fat may also
relate more to a negative self-esteem aspect
of depressive mood
Item was allowed to cross-load on the
Hypothyroid Symptoms and Depressivity and
Anxiety factors
Loaded −0.16 on Hypothyroid
Symptoms factor, −0.22 on
Anxiety and 0.15 on
Depressivity factor.
Loading on own factor: 0.53
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involved in such pairs would be potential candidates for
omission in future IRT-modeling of the instrument and in
the development of abbreviated versions of the ThyPRO.
However, such item reduction should be done with
caution and should take clinical analyses and consider-
ations into account.
Although positively worded items did tend to exhibit
residual correlations, we found no consistent evidence
of a method factor among the positively worded items.
Similar studies with other outcome measures have pre-
viously found substantial influence of the value of the
wording [36,42-44], whereas other studies either did not
identify such an effect [45] or the identified effect had
only minor influence on the results regarding the sub-
stantive factor [46].
We attempted to model potential item misfit identified
during the dimensionality analyses of the existing ThyPRO
scales. This was done within a model including all scales,
which were allowed to correlate, in order to allow for
cross-loadings of items to be examined and in order to
evaluate if possible misfit identified during individual scale
analyses was due to interrelation with other factors. In
doing so, the hypothesized reason for misfit was con-
firmed in five of seven items: Item 2b, about visibility of
the goiter, cross-loaded on Cosmetic Complaints. Item 2t,
Loose stools, had a large negative loading on Hypothyroid
Symptoms, as had 2l, Hoarseness. Both constipation and
hoarseness are indeed salient and classical features of
hypothyroidism [47]. The rather non-specific item 13g,
Feeling too fat, which is a common complaint among
hypothyroid patients and among hyperthyroid patients
after treatment, had cross-loadings on several other scales
and low loading on its own factor, also when modeled
multidimensionally. Thus, these four items are very strong
candidates for item reduction when developing abbrevi-
ated and focused versions of the scales or when fitting
models where unidimensionality is a strong assumption,
for example as in unidimensional IRT models.
A unique “duration of disease”-effect was observed for
one item. Item 6d, Afraid of being seriously ill was nega-
tively associated with time since diagnosis, indicating
that the responses to this item reflects a relevant con-
cern early in the disease course, for instance of a goiter
being malignant, a concern that wanes as the diagnosis
becomes more firmly established and malignancy thus
ruled out. It thus measures something different from the
other items in the scale, which are more classical indica-
tors of an anxious state.
As an analysis of the robustness and appropriateness
of the ordinal confirmatory WLSMV factor analysis, an
alternative multidimensional IRT-based analysis was per-
formed. Individual factor scores derived from each of
these approaches were very similar, as illustrated by very
high intra-class correlation coefficients. This corrobo-
rates the current simple scoring approach and the re-
sults of the present analyses.
The use of theoretically driven analyses within a clinic-
ally well-described and relatively (for thyroid diseases)
large sample was a strength of this study. However, the
analyses were carried out in one sample and should ideally
be confirmed in a new independent sample. Furthermore,
although the present sample comprised patients in all
stages of disease and treatment, stability of the factor
structure across time could not be evaluated, since the
data did not contain longitudinal measurements.
In conclusion, each of the ThyPRO scales could be
appropriately represented by a unidimensional model after
minor revisions. Eleven items were identified in the unidi-
mensional models as potentially misfitting and understood
further by multidimensional modeling. Thus, overall the
previous initial examinations of the construct validity of
the scales [12] were corroborated using a more elaborate
technique. Further, advanced psychometric modeling such
as IRT, with strong assumptions about dimensionality, can
be applied to the reduced scales. Finally, the locally
dependent items identified here are strong candidates for
removal, in future item reduction processes.
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